From: Decreased expression of stomatin predicts poor prognosis in HER2-positive breast cancer
Distant metastases | ||
---|---|---|
Parameter | Risk ratio (95 % CIa) | p |
Hormonal receptors‡ | 0.405 | |
ER (+) or PR (+) | 1.0 (referent) | |
ER (−) and PR (−) | 1.5 (0.6 to 4.3) | |
Stage | 0.016 | |
I–II | 1.0 (referent) | |
III | 3.5 (1.3 to 9.9) | |
Adjuvant trastuzumab | 0.147 | |
Yes | 1.0 (referent) | |
No | 3.1 (0.7 to 14.8) | |
Stomatin expression | 0.017 | |
Positive | 1.0 (referent) | |
Negative | 4.0 (1.3 to 12.5) |